In 2024, 26.5% of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables.

Eli Lilly said its once-daily weight loss pill was effective for people with obesity and type 2 diabetes in a key trial, ...

Eli Lilly has announced to go for global approval by the end of 2015 after completing the successful trials. The once-daily ...

Stock index futures fell on Tuesday, as President Donald Trump fired Federal Reserve Governor Lisa Cook on Monday amid ...

Male and female fat deposit distribution was associated with an increased cardiovascular age-delta; however, some adiposity ...